Single User License
INR 11811
Site License
INR 23622
Corporate User License
INR 35432

Service Tax Additional

select a format
Price

Single User License
USD 175
Site License
USD 350
Corporate User License
USD 525

Alternatively

Request a quote
Request a Customized research
Request for Sample Report





Recent Viewed Reports


Why Ken Reasearch?


Testimonials

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"

Ken Research completed the report successfully with tough deadline and large requirement. Really appreciate it... "Sales Manager, Largest India Aesthetic Laser Manufacturer"

We found the report really useful in understanding the complex Indian market and it provided lots of high quality insights. On the basis of this we commissioned Ken to produce a bespoke follow up to answer some specific questions about our market. This is now being used to help develop our marketing and sales strategy. We were very pleased with the comprehensive coverage, detail provided and actionable insights.... "Owner, Therefore Consulting UK"


Cubist Pharmaceuticals, Inc.-Strategy, SWOT and Corporate Finance Report

Cubist Pharmaceuticals, Inc.-Strategy, SWOT and Corporate Finance Report


  Request for Sample Report

Executive Summary

Cubist Pharmaceuticals, Inc.-Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360? view of the company.

Key Findings

Detailed information on Cubist Pharmaceuticals, Inc. required for business and competitor intelligence needs

A study of the major internal and external factors affecting Cubist Pharmaceuticals, Inc. in the form of a SWOT analysis

An in-depth view of the business model of Cubist Pharmaceuticals, Inc. including a breakdown and examination of key business segments

Intelligence on Cubist Pharmaceuticals, Inc.'s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors

News about Cubist Pharmaceuticals, Inc., such as business expansion, restructuring, and contract wins

Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons To Buy

Gain understanding of Cubist Pharmaceuticals, Inc. and the factors that influence its strategies

Track strategic initiatives of the company and latest corporate news and actions

Assess Cubist Pharmaceuticals, Inc. as a prospective partner, vendor or supplier

Support sales activities by understanding your customers' businesses better

Stay up to date on Cubist Pharmaceuticals, Inc.'s business structure, strategy and prospects

Key Highlights

Cubist Pharmaceuticals (Cubist or 'the company') is a biopharmaceutical company focused on the research, development and commercialization of pharmaceutical products that address unmet medical needs in the acute care environment. The company operates primarily in the US. Cubist is headquartered in Lexington, Massachusetts, and employed 873 people as of February 01, 2014.

Company Snapshot

Cubist Pharmaceuticals, Inc.: Company Overview

Cubist Pharmaceuticals, Inc.: Overview and Key Facts

Cubist Pharmaceuticals, Inc.: Overview

Cubist Pharmaceuticals, Inc.: Key Facts

Cubist Pharmaceuticals, Inc.: Key Employees

Cubist Pharmaceuticals, Inc.: Key Employee Biographies

Cubist Pharmaceuticals, Inc.: Major Products and Services

Cubist Pharmaceuticals, Inc.: Company History

Cubist Pharmaceuticals, Inc.: Management Statement

Cubist Pharmaceuticals, Inc.: Locations and Subsidiaries

Cubist Pharmaceuticals, Inc.: Key Competitors

Cubist Pharmaceuticals, Inc.: Company Analysis

Cubist Pharmaceuticals, Inc.: Business Description

Cubist Pharmaceuticals, Inc.: SWOT Analysis

Cubist Pharmaceuticals, Inc.: SWOT Overview

Cubist Pharmaceuticals, Inc.: Strengths

Cubist Pharmaceuticals, Inc.: Weaknesses

Cubist Pharmaceuticals, Inc.: Opportunities

Cubist Pharmaceuticals, Inc.: Threats

Cubist Pharmaceuticals, Inc.: Corporate Financial Deals Activity

Cubist Pharmaceuticals, Inc.: Financial Deals Overview

Cubist Pharmaceuticals, Inc.: Targets and Partners

Cubist Pharmaceuticals, Inc.: Top Deals 2012-2016YTD*

Cubist Pharmaceuticals, Inc.: Advisors

Cubist Pharmaceuticals, Inc.: Top Legal Advisors

Cubist Pharmaceuticals, Inc.: Top Financial Advisors

Cubist Pharmaceuticals, Inc.: Mergers and Acquisitions

Cubist Pharmaceuticals, Inc.: Capital Raising

Cubist Pharmaceuticals, Inc.: Partnership

Cubist Pharmaceuticals, Inc.: Private Equity and Ownership

Cubist Pharmaceuticals, Inc.: Recent Developments

Cubist Pharmaceuticals, Inc.: News and Events Summary

Cubist Pharmaceuticals, Inc.: Business Expansion

Cubist Pharmaceuticals, Inc.: Corporate Governance

Cubist Pharmaceuticals, Inc.: Financial Performance

Cubist Pharmaceuticals, Inc.: Red Flags/DistressSignals

Cubist Pharmaceuticals, Inc.: Regulatory and Legal Events

Cubist Pharmaceuticals, Inc.: Research & Development

Appendix

Contact Us

Methodology

Definitions

About Datamonitor

Figure 1: Cubist Pharmaceuticals, Inc.: Deal Activity by Deal Type-Volume (2012-YTD*2016)

Figure 2: Cubist Pharmaceuticals, Inc.: M&A Average Deal Size-Value (US$m)

Figure 3: Cubist Pharmaceuticals, Inc.: M&A Volume and Value Trend (2012-YTD*2016)

Figure 4: Cubist Pharmaceuticals, Inc.: M&A Activity by Geography (2012-YTD*2016)

Figure 5: Cubist Pharmaceuticals, Inc.: Capital Raising Volume and Value Trend (2012-YTD*2016)

Figure 6: Cubist Pharmaceuticals, Inc.: Capital Raising by Deal Type (2012-YTD*2016)

Figure 7: Cubist Pharmaceuticals, Inc.: Partnership Volume and Value Trend (2012-YTD*2016)

Figure 8: Cubist Pharmaceuticals, Inc.: Partnership Trend by Deal Type (2012-YTD*2016)

Figure 9: Cubist Pharmaceuticals, Inc.: Private Equity and Ownership Volume and Value Trend (2012-YTD*2016)

Figure 10: Cubist Pharmaceuticals, Inc.: Private Equity and Ownership Volume by Deal Type (2012-YTD*2016)

Table 1: Cubist Pharmaceuticals, Inc.: Key Facts

Table 2: Cubist Pharmaceuticals, Inc.: Key Employees

Table 4: Cubist Pharmaceuticals, Inc.: Key Competitors

Table 5: Cubist Pharmaceuticals, Inc.: Deal Activity by Deal Type-Volume (2012-YTD*2016)

Table 6: Cubist Pharmaceuticals, Inc.: M&A Average Deal Size-Value (US$m)

Table 7: Cubist Pharmaceuticals, Inc.: Targets and Partners

Table 8: Cubist Pharmaceuticals, Inc.: Top Deals 2012-2016YTD*

Table 9: Cubist Pharmaceuticals, Inc.: Legal Advisor Ranking by Value (US$m)

Table 10: Cubist Pharmaceuticals, Inc.: Financial Advisor Ranking by Value (US$m)

Table 11: Cubist Pharmaceuticals, Inc.: M&A Volume and Value Trend (2012-YTD*2016)

Table 12: Cubist Pharmaceuticals, Inc.: M&A Activity by Geography (2012-YTD*2016)

Table 13: Cubist Pharmaceuticals, Inc.: Capital Raising Volume and Value Trend (2012-YTD*2016)

Table 14: Cubist Pharmaceuticals, Inc.: Capital Raising by Deal Type (2012-YTD*2016)

Table 15: Cubist Pharmaceuticals, Inc.: Partnership Volume and Value Trend (2012-YTD*2016)

Table 16: Cubist Pharmaceuticals, Inc.: Partnership Trend by Deal Type (2012-YTD*2016)

Table 17: Cubist Pharmaceuticals, Inc.: Private Equity and Ownership Volume and Value Trend (2012-YTD*2016)

Table 18: Cubist Pharmaceuticals, Inc.: Private Equity and Ownership Volume by Deal Type (2012-YTD*2016)

Table 19: Cubist Pharmaceuticals, Inc.: News and Events Summary

Table 20: Cubist Pharmaceuticals, Inc.: Business Expansion

Table 21: Cubist Pharmaceuticals, Inc.: Corporate Governance

Table 22: Cubist Pharmaceuticals, Inc.: Financial Performance

Table 23: Cubist Pharmaceuticals, Inc.: Red Flags/DistressSignals

Table 24: Cubist Pharmaceuticals, Inc.: Regulatory and Legal Events

Table 25: Cubist Pharmaceuticals, Inc.: Research & Development

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Cubist Pharmaceuticals, Inc.


Related Products in vertical
Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204

download

Company Brochure

Engage with Us

query [@] kenresearch.com